Table 1.
Clinical and physiological characteristics of patients with NAFLD or C-CH.
| NAFLD (=37) | C-CH (=40) | P value | |
|---|---|---|---|
| Gender (F/M) | 19/18 | 17/23 | ns |
| Age (yo) | 54.4 ± 16.2 | 69.5 ± 9.5 | <0.001 |
| BMI (Kg/m2) | 29.6 ± 7.3 | 24.0 ± 3.7 | <0.001 |
| FBS (mg/dl) | 11.5 ± 29.8 | 113.4 ± 41.9 | ns |
| f-IRI (μU/ml) | 19.4 ± 17.1 | 11.1 ± 6.9 | <0.05 |
| HOMA-IR | 5.15 ± 4.70 | 3.18 ± 2.22 | <0.05 |
| HbA1c (%) | 6.3 ± 1.6 | 6.3 ± 1.3 | ns |
| 1,5-AG (μg/ml) | 15.3 ± 7.6 | 15.3 ± 10.3 | ns |
| AST (IU/L) | 64.9 ± 26.7 | 55.8 ± 26.0 | ns |
| ALT (IU/L) | 89.7 ± 49.4 | 43.7 ± 22.9 | <0.001 |
| ALP (IU/L) | 275.1 ± 69.8 | 387.8 ± 163.1 | <0.001 |
| GGT (IU/L) | 101.5 ± 82.9 | 68.3 ± 75.7 | ns |
| T-Bil (mg/dl) | 0.93 ± 0.41 | 1.05 ± 0.85 | ns |
| TP (g/dl) | 7.4 ± 0.5 | 7.2 ± 0.7 | ns |
| ALB (g/dl) | 4.4 ± 0.5 | 3.5 ± 0.7 | <0.001 |
| T-CHO (mg/dl) | 201.7 ± 33.4 | 149.9 ± 33.1 | <0.001 |
| TG (mg/dl) | 152.5 ± 71.9 | 103.7 ± 50.1 | <0.005 |
| RBC (×104/μl) | 460.0 ± 52.1 | 384.3 ± 54.2 | <0.001 |
| Hb (g/dl) | 14.3 ± 1.4 | 12.4 ± 1.7 | <0.001 |
| PLT (×104/μl) | 18.9 ± 6.9 | 12.8 ± 6.6 | <0.001 |
| WBC (×103/μl) | 6.0 ± 1.5 | 5.0 ± 2.0 | <0.05 |
| IV collagen 7S (ng/ml) | 5.1 ± 2.1 | 8.8 ± 3.7 | <0.001 |
| P-3-P (U/ml) | 0.7 ± 0.3 | 1.2 ± 0.3 | <0.001 |
| FIB-4 index | 2.69 ± 2.07 | 6.69 ± 5.61 | <0.001 |
| PT (INR) | 1.04 ± 0.08 | 1.16 ± 0.22 | <0.005 |